ELOCTATE 500

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

COAGULATION FACTOR VIII

Tersedia dari:

SANOFI - AVENTIS ISRAEL LTD

Kode ATC:

B02BD05

Bentuk farmasi:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Komposisi:

COAGULATION FACTOR VIII 500 IU

Rute administrasi :

I.V

Jenis Resep:

Required

Diproduksi oleh:

BIOGEN IDEC LIMITED , UK

Area terapi:

COAGULATION FACTOR VII

Indikasi Terapi:

ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children 12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.

Tanggal Otorisasi:

2017-01-09